Narcolepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with narcolepsy (main study group):
- You are an adult who has been diagnosed with Type 1 narcolepsy based on recognised medical guidelines and have completed a 48-hour sleep study at a Sleep Laboratory
- You are part of a social security system (such as having health insurance or national healthcare coverage)
For the comparison group (people without narcolepsy):
- You are 18 years of age or older
- You are being treated at Toulouse University Hospital for obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) and your treatment is working well, showing little to no remaining sleep apnea
- You are part of a social security system (such as having health insurance or national healthcare coverage)
Who may not be able to join:
- You have a history of autism spectrum disorder, a long-term psychotic disorder, or bipolar disorder
- You have a history of memory or thinking difficulties caused by a neurological condition (a condition affecting the brain or nervous system)
- Your level of French language understanding is not sufficient to complete the study questionnaires
- You are currently under a legal protection measure, guardianship, or curatorship (a formal arrangement where someone else manages your affairs)
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rachel DEBS, MD, Centre de compétence Narcolepsies et Hypersomnies rares, CHU de Toulouse, Hôpital Pierre-Paul Riquet
Phone: 05 61 77 94 88
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of mentalization abilities, in a population of patients with NT1 versus a control group.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.